patent office circular

Are methods of calculating ridiculous alleged legal costs trade-secrets?

     Teva successfully opposed IL 184027 to Novartis titled “COMPOUND TRISODIUM [3-((1S,3R)-1- BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1- BUTYLCARBAMOYL)PROPIONATE-(S)- 3¶METHYL-2¶PENTANOYL{2¶¶ TETRAZOL-5-YLATE)BIPHENYL- 4¶YLMETHYL}AMINO)BUTYRATE] HEMIPENTAHYDRATE, ITS PHARMACEUTICAL COMPOSITIONS, METHOD FOR ITS PREPARATION AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS.” The application was filed on 18… Read More ›

Long Division

IL 234696 to Genentech relates to the antibody that is the active ingredient in its blockbuster drug Herceptin. The Application is a divisional application of IL 214084 which is itself a divisional application of 136201. Section 24 of the Israel Patent 1967 states… Read More ›